0.945
Prelude Therapeutics Inc Aktie (PRLD) Neueste Nachrichten
Chart overlay techniques for tracking Prelude Therapeutics IncorporatedQuarterly Investment Review & High Conviction Investment Ideas - Newser
Prelude Cuts Q2 Losses and Costs 13% - The Motley Fool
Prelude (PRLD) Announces Q2 2025 Results; Presentation Attached | PRLD SEC FilingForm 8-K - Stock Titan
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance
Prelude Therapeutics Incorporated recovery potential after sell offJuly 2025 Levels & Weekly High Return Opportunities - Newser
Price momentum metrics for Prelude Therapeutics Incorporated explainedEarnings Recap Summary & Short-Term Swing Trade Alerts - Newser
Will Prelude Therapeutics Incorporated bounce back from current supportForecast Cut & Precise Buy Zone Identification - Newser
Will Prelude Therapeutics Incorporated stock go up soon2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
Is it time to cut losses on Prelude Therapeutics IncorporatedJuly 2025 News Drivers & High Conviction Buy Zone Picks - Newser
Why Prelude Therapeutics Incorporated stock attracts strong analyst attention2025 Historical Comparison & Risk Controlled Stock Pick Alerts - Newser
Tick level data insight on Prelude Therapeutics Incorporated volatilityMarket Movement Recap & Accurate Entry and Exit Point Alerts - Newser
Quantitative breakdown of Prelude Therapeutics Incorporated recent moveJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
How to build a dashboard for Prelude Therapeutics Incorporated stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
What makes Prelude Therapeutics Incorporated stock price move sharplyEarnings Risk Report & Community Verified Swing Trade Signals - Newser
What recovery options are there for Prelude Therapeutics Incorporated [July 2025 Sentiment]High Yield Equity Trading Tips - Newser
Is Prelude Therapeutics Incorporated reversing from oversold territoryFree Value Investing Picks With Stability - Newser
Does Prelude Therapeutics Incorporated qualify in momentum factor screeningWatchlist Generator for Smart Money Signals - Newser
Prelude Therapeutics Incorporated stock trendline breakdownFree Trade Setups With Clear Risk Limits - Newser
Using data filters to optimize entry into Prelude Therapeutics IncorporatedAsset Safety Selection Using Quantitative Analysis - Newser
Published on: 2025-08-11 08:04:14 - Newser
Can Prelude Therapeutics (NASDAQ:PRLD) Afford To Invest In Growth? - Yahoo Finance
Prelude Therapeutics Incorporated’s volatility index tracking explainedMulti-Year Signal Summary and Entry Timing - Newser
Can machine learning forecast Prelude Therapeutics Incorporated recoveryLong Term Stock Planner with Safety Checks - Newser
Prelude Therapeutics (PRLD) to Release Quarterly Earnings on Monday - Defense World
Published on: 2025-08-08 17:57:29 - Newser
Prelude Therapeutics Inc expected to post a loss of 44 cents a shareEarnings Preview - TradingView
Has Prelude Therapeutics Incorporated found a price floorLong-Term Investment Strategy Summary Guide - Newser
Using fundamentals and technicals on Prelude Therapeutics IncorporatedTrend Following Ideas with Volume Confirmation - Newser
What recovery options are there for Prelude Therapeutics IncorporatedFree Swing Trade Entry With Volume Triggers - Newser
Using data models to predict Prelude Therapeutics Incorporated stock movementFree ROI Boosting Trade Opportunity Calendar - Newser
Is Prelude Therapeutics Incorporated stock entering bullish territoryPre-Market Stock Movement Summary and Review - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):